Bain Capital's buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group.
Get insights on how to enhance specific areas of your practice, such as provider and scheduling performance, contact center efficiency and much more. Download the Guide Now.
It's time to replace this system with one that works for patients and invites disruption. We need to put control back in the hands of patients, allowing them to own their health records, make independent decisions, and switch to fair and transparent alternatives.
The evolving landscape of healthcare demands that health plans continuously refine their engagement strategies, making this decision more critical than ever. Plan leaders must consider key factors, including cost, speed, scalability, and effectiveness, to guide them toward the most impactful approach.
We kick off our first season of the MedCity Pivot Podcast by discussing ways healthcare organizations can protect themselves from being targets of a cybersecurity attack. A new IEEE Standard can help.
No comments